Industry news

Rusnano opens new nanotechnology center in Russia

ITAR TASS

The Dubna nanocenter is focused on commercialization of nanotechnology projects in the CIS and integration into the global innovation system

EMA Recommends 39 Drugs in First Half of 2014

BioPharm International

Thirty-nine drugs were recommended for marketing authorization by the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) in the first half of 2014, compared with 44 in first half of 2013 and 33 in first half of 2012. The recommended drugs included drugs designed to fill unmet medical needs, treat diseases for which no treatments were previously available, or bring significant added benefit to patients over existing therapies.

Russian start-up launches web-based cancer diagnosis service

Marchmount Innovation News

Russian start-up Unim (United Medicine) has launched the Unim Histology Internet service, which will make it possible for cancer patients to send analyses remotely to the Dmitri Rogachev Federal Clinical and Research Center for Pediatric Hematology, Oncology, and Immunology in Moscow,  reported  East-West Digital News, the first all English-language online resource dedicated to Russian digital industries. 

Solid technology, smart decisions at the heart of Regeneron's remarkable R&D productivity

Michael Flanagan, FirstWord Lists

Regeneron Pharmaceuticals has emerged as one of the most prolific wellsprings of new antibody drugs in the biopharma universe thanks to its success in combining innovative technologies with intelligent target selection.

Russian patients will be available to innovative treatments for skin cancer

RU.facts

In recent years, the world is rapidly increasing incidence of cancer including skin cancer, which accounted for Russia in the structure of malignant tumors account for 10.7% and each year this figure grows by 2-3%. This arises primarily environmental degradation and the harmful effects of ultraviolet radiation from the sun, having a carcinogenic effect.

Bullish On Russian Pharmaceutical Market Despite Risks

Business Monitor: News & Views

Demographic trends, rising incomes and greater state spending on healthcare will drive growth within the Russian pharmaceutical sector. However, we also see risks to investment and considerable barriers for foreign companies. On balance, we remain bullish on the growth prospects for Russian pharmaceutical spending, but highlight local companies as having better opportunities to realise this growth than multinationals.

Russia may have its own curing HIV vaccine in 3-4 years

Marchmount Innovation News

Russia is expecting to have its own therapeutic vaccine to fight HIV in three-to-four years, following a series of clinical trials. Andrei Kozlov of the Federal Medical and Biological Agency, an official overseeing the vaccine project,  shared the news  with the Russian news agency RIA Novosti. 

New type of surgical complex being developed in Russia

Marchmount Innovation News

NPTs Biotechnology, a spin-off of Russia’s Institute of Design and Technology Informatics, is working on what is believed to be a next-generation robotic complex for surgeries, the Skolkovo Foundation website  reported . 
 

RF prime minister to present government awards to young scientists

ITAR TASS

Russia’s Prime Minister Dmitry Medvedev on Monday will present RF government awards for 2013 in the sphere of science and technology to young scientists.

Russia may have its own curing HIV vaccine in 3-4 years

Marchmount Innovation News

Russia is expecting to have its own therapeutic vaccine to fight HIV in three-to-four years, following a series of clinical trials. Andrei Kozlov of the Federal Medical and Biological Agency, an official overseeing the vaccine project,  shared the news  with the Russian news agency RIA Novosti.